The facility, located in Dessau, Germany, will go back to producing Takeda’s dengue vaccine candidate after a three-month period.
Takeda has agreed to help manufacture three different COVID-19 vaccines. The drugmaker has already begun manufacturing Moderna and Novavax vaccines to provide rapid and sustained COVID-19 vaccine access in Japan.
More articles on pharmacy:
No link between AstraZeneca vaccine, blood clots, WHO says, despite countries halting use
HHS allows retired pharmacists, pharmacy interns to give COVID-19 vaccinations
Gilead, Merck co-developing long-acting HIV treatment
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
